FeedThiogenesis Therapeutics, Corp. (Formerly Rozdil Capital Corporation)

Thiogenesis Therapeutics, Corp. (Formerly Rozdil Capital Corporation)

TSX

Total bought: $153.2K
Total sold: $0
Unique insiders: 2
Most recent trade: Sep 29, 2026
Highest signal score: 7.5 / 10Sep 29, 2026

100% bought0% sold

Insiders at this company

↑ Sep 29, 2026

↑ Sep 22, 2026

Trades

Thiogenesis Therapeutics, Corp. (Formerly Rozdil Capital Corporation)TSX

Riggins, Brook — Senior Officer

BUY$26.0K

Score 7.5/10

Sep 29

Thiogenesis Therapeutics, Corp. (Formerly Rozdil Capital Corporation)TSX

Aharon, Gilad — Director

BUY$127.2K

Score 6.8/10

Sep 22